revenue
550 $million
Q4 2016
official guidance
| Revenue | $2.5B |
|---|---|
| Operating income | $158.1M |
| Net income | $40.0M |
| Free cash flow | $84.8M |
| Operating margin | 6.3% |
| Net margin | 1.6% |
| Return on equity | 5.0% |
| Period | 2025 |
OpenFilings analyst
Agentic read of the latest earnings call — recommendation updates when we process a new transcript. Research synthesis, not investment advice.
Improving stability and integration upside are not yet enough to offset weak underlying demand and limited evidence of organic acceleration.
Latest call · Q2 2026Hold: IDEX sees stabilization in North American industrial markets, but not a convincing recovery—management explicitly said the $550 million Q4 revenue target is not a breakout and remains dependent on normal seasonality and visible business. The upside is execution and a targeted 500-basis-point profit improvement over three years at AWG and Akron; the tension is continued gas, international rescue, BAND-IT and broader industrial weakness, plus Brexit contagion risk.
Q4 revenue guidance of approximately $550 million is broadly similar to Q2, so the setup is for continuity rather than a meaningful sequential recovery.
Gas remained the outlier among industrial indicators, while BAND-IT and international rescue tools are expected to stay soft through the second half.
Q4 comparisons for Fire & Safety/Diversified become materially easier, potentially lifting reported organic growth without much operational improvement.
The $200 million private placement adds approximately $1 million of quarterly interest expense, or roughly $0.02 per share, in the second half.
Brexit has not yet caused customer delays, but management is watching for broader European contagion; the UK represents approximately 5% of revenue and is substantially hedged by costs.
AWG and Akron are targeted for approximately 500 basis points of profit improvement over three years, supported by channel overlap, portfolio expansion and integration into the existing fire/rescue platform.
Life sciences appear to be in the early-to-mid innings of a new-product cycle, while municipal spending has a multi-year backlog if there is no major macroeconomic shutdown.
Management claims 30% to 35% incremental margins if growth improves to 2% to 3%, with potentially higher incrementals at 3% to 4%; this remains a framework rather than demonstrated demand leverage.
The portfolio remains differentiated between growth businesses and structurally challenged businesses, but the call provided limited evidence that the growth program is accelerating organically.
Analysts repeatedly pressed for year-over-year order detail, but management could not provide the June figure and cautioned that one month is not a reliable indicator.
Management characterized conditions as stability rather than growth, while external distributor trends cited by analysts appeared weaker; the company dismissed the comparison because its exposure is more value-added, leaving the demand signal difficult to verify.
The CEO could not explain the reported MPVI new-product revenue reference during Q&A and deferred follow-up, weakening confidence in the visibility of the organic-growth narrative.
Approximately half of the $6 million of delayed energy-project revenue was already included in expectations, and management could not explain why customers ultimately took delivery, limiting confidence in repeatability.
International rescue weakness has persisted for roughly a year and a half, with management calling the recovery a wild card despite easier comparisons.
revenue
550 $million
Q4 2016
official guidance
OpenFilings analyst view from primary-source filings and earnings calls — not investment advice.
CENTURY ALUMINUM COMPANY
CENTURY ALUMINUM COMPANY
CENTURY ALUMINUM COMPANY
CENTURY ALUMINUM COMPANY
CENTURY ALUMINUM COMPANY
CENTURY ALUMINUM COMPANY